3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
7
Completed
2
Unknown
1
Terminated
1
Not yet recruiting
1
Approved for marketing
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Glioblastoma
82
Brain Neoplasms
79
Glioma
63
Neoplasms
16
Neuroblastoma
15
Meningioma
14
Medulloblastoma
13
Neurofibromatosis 1
10
Ependymoma
10
Meningeal Carcinomatosis
9
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
8
Neurologic Manifestations
6
Diffuse Intrinsic Pontine Glioma
6
Astrocytoma
6
Spinal Cord Neoplasms
5
Recurrence
5
Central Nervous System Neoplasms
5
Pheochromocytoma
4
Paraganglioma
4
Oligodendroglioma
4
Lung Neoplasms
4
Sarcoma
3
Rhabdoid Tumor
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neuroma, Acoustic
3
Neurofibroma, Plexiform
3
Head and Neck Neoplasms
3
Ganglioneuroblastoma
3
Interventions
trametinib
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Neoplasms by Histologic Type
×
CNS
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled